VPS51 pseudogene 15 (VPS51P15)

**VPS51 pseudogene 15 (VPS51P15) is classified as a pseudogene and not as a protein-coding gene or a functional therapeutic target.** There is no evidence supporting the production of a functional protein or involvement in molecular pathways, biological function, or disease roles typically associated with genuine therapeutic targets. The main protein-coding gene in this family is VPS51, which participates in endosomal trafficking and is implicated in neurodevelopmental diseases, but VPS51P15 itself does not code for a protein and is not a drug or therapeutic target[1][2][3].\n\n**Key points:**\n- VPS51P15 is a pseudogene and not involved in cellular protein function.\n- It is not a receptor, enzyme, transporter, or transcription factor.\n- No drug interactions, biomarker applications, or clinical safety concerns are reported for this locus.\n- It is not referenced as a therapeutic or disease-associated target in biomedical literature.\n- The main functional gene of this family is VPS51, not VPS51P15.\n- If you meant to refer to the protein-coding VPS51 (VPS51 subunit of GARP complex), that is a distinct entity with established cellular roles[1][2][3].\n\n**There is something incorrect about using VPS51P15 as a therapeutic target: it is a pseudogene, not a drug target or functional molecule.**

Other names

VPS51P15